Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

MTB early secretory antigenic target 28-36, LLDEGKQSL, 10 mg Peptide

M. tuberculosis (strain ATCC 25618 / H37Rv) 6 kDa early secretory antigenic target 28-36, LLDEGKQSL US$533.00 Excluding tax and shipping fees Limited stock Description About M. tuberculosis (strain ATCC 25618 / H37Rv) 6 kDa early secretory antigenic target 28-

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

M. tuberculosis (strain ATCC 25618 / H37Rv) 6 kDa early secretory antigenic target 28-36, LLDEGKQSL

US$533.00

Excluding tax and shipping fees

Limited stock

Description

About M. tuberculosis (strain ATCC 25618 / H37Rv) 6 kDa early secretory antigenic target 28-36, LLDEGKQSL

The M. tuberculosis (strain ATCC 25618 / H37Rv) 6 kDa early secretory antigenic target Peptide (IEDB: 37146) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The 6 kDa early secretory antigenic target Peptide, H-LLDEGKQSL-OH (Uniprot: P9WNK7 aa: 28-36) from JPT is produced under strict quality control and quality management.

M. tuberculosis (strain ATCC 25618 / H37Rv) 6 kDa early secretory antigenic target 28-36, LLDEGKQSL - Specifications

Peptide sequence: H-LLDEGKQSL-OH

Amount: 10 mg (10 x 1 mg)

Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)

Counterion: TFA

Delivery Format: Freeze-dried in plastic vial

Application(s): T-cell Immunity

Condition(s)/Topic(s): Tuberculosis

Standard Delivery Time: approx. 3 weeks

Your Custom or Scrambled Antigen Peptide!

Do you need a scrambled version of this antigen peptide?We can produce scrambled versions for all our antigen peptides and other peptide sequences. These scrambled peptide versions are cross-checked against the Uniprot database to ensure that the scrambled sequence does not correspond to any natural sequence. Have a look at Scrambled Antigen Peptides!

Are you interested in other antigen peptides?Choose sequence, amount and purity. We will assist you along the way: Custom Peptide Synthesis

JPT’s Antigen PeptidesFind your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.Not found what you are looking for? Take a look at our Custom Peptide Synthesis!

Benefits of JPT’s Antigen Peptides- All peptides are made in Germany- Bulk orders or custom peptide snythesis upon request- Synthesis protocols designed to avoid toxic contaminants and side products - Provision of freeze dried aliquots for enhanced stability - Proven track record for applications in clinical studies- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for M. tuberculosis (strain ATCC 25618 / H37Rv) 6 kDa early secretory antigenic target 28-36, LLDEGKQSL

References:Read References with Antigen Peptides

Documentation

Documentation for M. tuberculosis (strain ATCC 25618 / H37Rv) 6 kDa early secretory antigenic target 28-36, LLDEGKQSL

Protocol_PepMix.pdf

MTBs-6kDa-early-secretory-antigenic-target-28-3-3.pdf

Properties

Properties of M. tuberculosis (strain ATCC 25618 / H37Rv) 6 kDa early secretory antigenic target 28-36, LLDEGKQSL

T-cell immunity

Antigen Peptides

Tuberculosis

Freeze-dried in glass vial, Freeze-dried in plastic vial

M. tuberculosis

6 kDa early secretory antigenic target

Trial Grade: each peptide purified to > 90% (HPLC/MS)

No

Further Information to M. tuberculosis (strain ATCC 25618 / H37Rv) 6 kDa early secretory antigenic target 28-36, LLDEGKQSL

Values

H-LLDEGKQSL-OH

9mer peptide as TFA salt

Related Products

Related Products

M. tuberculosis ESAT-6-like protein EsxH 41-55, SAWQGDTGITYQAWQ

US$178.10

M. tuberculosis Probable serine protease PepA 61-75, PQVVNINTKLGYNNA

M. tuberculosis ESAT-6-like protein EsxH 1-15, MSQIMYNYPAMLGHA

M. tuberculosis (strain CDC 1551 / Oshkosh) PPE2 130-137, GINTIPIAL

P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →